Discover 2,450 paid clinical trials in North Carolina. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
From paid studies for healthy volunteers to condition-specific trials, North Carolina offers a wide range of clinical research opportunities. Leading medical centers in Charlotte, Raleigh, and Durham are seeking participants, providing access to innovative treatments and comprehensive care.
Filter
1
Filter results
Results: 2,450
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
for
Atrial Fibrillation (AF)
Location: Mira Road, Halifax, Bangor ME, Fall River MA, Boston MA,
Sponsor: Anthos Therapeutics, Inc.
Sex: All
Age: 65+
Code: NCT05712200
Phase3, Recruiting
A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects
for
Neuroblastoma, Neuroectodermal Tumors, Neoplasms
Location: Boston MA, New Hyde Park NY, New York NY,
Sponsor: Jubilant DraxImage Inc.
Sex: All
Age: 1+
Code: NCT03561259
Phase2, Recruiting
Patient Retrospective Outcomes (PRO)
for
Chronic Pain
Location: The Bronx NY, New Bern NC, Jupiter FL, Vero Beach FL,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT01550575
Recruiting
Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
for
Ulcerative Colitis
Location: The Bronx NY, Greenville NC, Indianapolis IN,
Sponsor: Bausch Health Americas, Inc.
Sex: All
Age: 5 - 17
Code: NCT04314375
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: St. John's, Halifax, Moncton, Portland ME, Boston MA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ethicon Pelvic Mesh Post Market Clinical Follow-up Registry
for
Stress Urinary Incontinence, Pelvic Organ Prolapse
Location: New Haven CT, Philadelphia PA, Durham NC, Pittsburgh PA
Sponsor: Ethicon, Inc.
Sex: Female
Age: 21+
Code: NCT04829175
Recruiting
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
for
Polymyositis, Dermatomyositis
Location: Boston MA, New Haven CT, Great Neck NY, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06455449
Phase3, Recruiting
Optimizing Perioperative Analgesia to Lower Pain Following Cleft Palate Surgery
for
Cleft Palate, Pain, Postoperative Care, Perioperative Care,
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 0 - 4
Code: NCT06962306
Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
for
Psychosis Associated With Alzheimer's Disease
Location: Farmington CT, Woodmere NY, West Palm Beach FL,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Sex: All
Age: 55 - 70+
Code: NCT05980949
Phase3, Recruiting
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Sponsor: UNC Lineberger Comprehensive Cancer Center
Sex: All
Age: 18 - 70+
Code: NCT01137643
Recruiting
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
for
Amblyopia
Location: Boston MA, Milford CT, New York NY, Philadelphia PA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 3 - 13
Code: NCT04378790
Phase3, Recruiting
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
for
Propionic Acidemia
Location: New York NY, Philadelphia PA, Durham NC, Toronto,
Sponsor: ModernaTX, Inc.
Sex: All
Age: 0+
Code: NCT04159103
Phase1, Phase2, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)